Latest stories on CAI
Caris Life Sciences initiated with a Neutral at UBS
The Fly50 · neutralanalyst
Caris Life Sciences to present new research at IASCL 2026
The Fly56 · neutralproduct/pr
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
PR Newswire65 · bullishproduct/pr
CAI Protective Collar Options for Caris Life Sciences Stock
Barchart50 · neutralgeneral
Calian Boosts Capital Flexibility With New Buyback Plan and Shelf Prospectus
TipRanks56 · neutralgeneral
Calian completes acquisition of Galaxy Broadband
GlobeNewswire62 · neutralm&a
Calian Group Ltd. 2026 Q3 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Calian Group 3Q Profit, Revenue Rise on Defense, Space Demand
MarketWatch67 · bullishearnings
Caris Life Sciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Caris Life Sciences Price Target Raised To 33 From 32 At Btig
The Fly56 · neutralanalyst
What’s Next For Caris Life Sciences (CAI) After 21% Jump?
Yahoo Top56 · neutralgeneral
Caris Life Sciences: Guidance Raised, Valuation Still Attractive
Seeking Alpha67 · bullishearnings
CAI’s 45% Revenue Surge and Raised Guidance Signal Strong Year Ahead: Highlights from Caris Life Sciences’ Q2 2026 Report
August 6, 2026
MarketChameleon73 · bullishearnings
Caris forecasts $1.03B-$1.04B 2026 revenue as it scales Detect capacity toward $3B run rate
Seeking Alpha73 · bullishearnings
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Caris Life Sciences Q2 Earnings Call Highlights
Yahoo Top73 · bullishearnings
Caris Life Sciences, Inc. GAAP EPS of $0.00 misses by $0.01, revenue of $263.7M beats by $25.62M
Seeking Alpha56 · neutralearnings
Caris Life Sciences, Inc. (CAI) files 8-K
SEC 8-K50 · neutralgeneral
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
PR Newswire73 · bullishearnings
Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection
Seeking Alpha67 · bullishproduct/pr
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
PR Newswire50 · neutralearnings
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
PR Newswire67 · bullishproduct/pr
CAI Closes Recapitalization with JLL Partners, Unlocking New Opportunities for Growth
PR Newswire67 · bullishgeneral